ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

Budget Year

November 12, 2010

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

In Brief: Brian Henderson Names New Director Of USC Comprehensible Cancer Center, Norris Hospital

April 8, 1983

New Drug Combination Improves Survival Of Ewing’s Sarcoma, Pediatric Study Finds

February 28, 2003